Indian Cambrex Plant Receives EU GMP Approval

Cambrex's manufacturing facility at Hyderabad, India has received good manufacturing practice (GMP) approval from Danish authorities, allowing the company to speed the export of products made at the site to Europe. The site produces nicotine replacement therapy lozenges and chewing gums, and other pharmaceutical products. The Danish GMP approval certificate is recognized by other EU countries, as well, Cambrex says. "This commercially important and significant milestone for Cambrex confirms our commitment to quality in every aspect of operations management...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers